Bimekizumab Safe and Effective for Moderate-To-Severe Hidradenitis Suppurativa Treatment
1. Significantly more patients in the bimekizumab group than placebo reported improved clinical...
Read MoreJun 15, 2024
1. Significantly more patients in the bimekizumab group than placebo reported improved clinical...
Read MoreJun 15, 2024
1. Administration of antibiotics beyond 330 minutes from emergency department arrival in pediatric...
Read MoreJun 15, 2024
The purpose of this study was to conduct a scoping review to describe the evidence on the efficacy...
Read MoreJun 14, 2024
1. In this randomized controlled trial, a self-expanding supra-annular valve was superior to a...
Read MoreJun 14, 2024
During 2016 to 2021, an estimated 1.4 million emergency department visits were made per year among...
Read MoreJun 14, 2024
If the Affordable Care Act were terminated, “that would mean over a hundred million Americans will lose protections for preexisting conditions.” President Joe Biden in a campaign advertisement, May 8 President Joe...
Read MoreJun 14, 2024
KFF Health News senior correspondent Angela Hart appeared on Spectrum News 1’s “LA Times Today” last week to explain how California is trying to help hard-drug users kick their habit by paying them to stay...
Read MoreJun 14, 2024
For Diana Perez, a medical resident at the Family Health Center of Harlem, the handwritten thank-you note she received from a patient is all the evidence she needs that she has chosen the right training path. Perez helped the...
Read MoreJun 14, 2024
The Host Julie Rovner KFF Health News @jrovner Read Julie’s stories. Julie Rovner is chief Washington correspondent and host of KFF Health News’ weekly health policy news podcast, “What the Health?” A...
Read MoreJun 14, 2024
Click here to read this study in NEJM. ©2024 2 Minute Medicine, Inc. All rights reserved. No...
Read MoreJun 14, 2024
1. In this cohort study of families with suspected Mendelian disorders for whom preliminary...
Read MoreJun 14, 2024
1. Across a median follow-up of 48.5 months, usage of tebentafusp for patients with metastatic...
Read MoreJun 14, 2024
1. In this randomized controlled trial, among patients with centrosomal protein 290...
Read MoreJun 14, 2024
THURSDAY, June 13, 2024 (HealthDay News) — Johnson & Johnson will pay $700 million to...
Read MoreJun 14, 2024
THURSDAY, June 13, 2024 (HealthDay News) — The U.S. Supreme Court on Thursday threw out a...
Read MoreJun 14, 2024
Women with a history of low birth-weight (LBW) delivery may have poorer cognition, according to a...
Read MoreJun 14, 2024
THURSDAY, June 13, 2024 (HealthDay News) — For patients with metabolic...
Read MoreJun 14, 2024
THURSDAY, June 13, 2024 (HealthDay News) — Alternative pembrolizumab administration...
Read MoreJun 14, 2024
Select patients with progressive multiple sclerosis (MS) may benefit from mesenchymal stem...
Read MoreJun 14, 2024
A linear change in depressive symptoms is associated with accelerated memory change and vice versa...
Read More